Matches in SemOpenAlex for { <https://semopenalex.org/work/W2327242544> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2327242544 abstract "BACKGROUND: Brain tumors represent the leading cause of childhood cancer mortality, of which medulloblastoma (MB) is the most frequent malignant pediatric brain tumor. Recent studies have demonstrated the presence of several MB molecular subgroups, each distinct in terms of prognosis and predicted therapeutic response. Although, group 2 MBs characterized by activation of the sonic hedgehog (Shh) signaling pathway have been of particular therapeutic interest, treatment-resistance has posed a significant challenge. Given the identification of brain tumor-initiating cells (BTICs), which have the ability to initiate and maintain tumor growth while promoting resistance to radio- and chemotherapy, we investigated the mechanistic profile of treatment-resistant Shh-dependent MB BTICs. METHODS: Through investigating a differential stem cell gene expression profile of 325 primary human MBs, followed by a subsequent series of step-wise knockdown, overexpression, chromatin immunoprecipitation (ChIP), and in vitro self-renewal analyses we assessed the mechanistic role of Sox2 as a novel downstream target of Shh effector proteins, Gli1 and Gli2. We further determined the clinical utility of this mechanism by treating our MB BTICs with conventional radio- and chemotherapy as per the Children's Oncology Group (COG) protocol for MB patients in order to assess the validity of Sox2 as a marker of Shh-dependent treatment-refractory MB BTICs. RESULTS: Activation and inhibition of the Shh pathway and Sox2 expression using small molecule Shh agonists and antagonists, respectively, were observed only in distinct subsets of tumor cells (CD15+ MB BTICs). ChIP experiments further demonstrated the presence of a differential Shh signaling mechanism within distinct cell populations of the bulk tumor mass as Gli proteins showed Sox2 promoter binding only in CD15+ MB BTICs. The functional relevance of this cell-specific signaling mechanism was assessed through an in vitro and in vivo increase in treatment-resistant Sox2+ MB BTICs following conventional and combinatorial radio- and chemotherapy with Shh pathway inhibitors. CONCLUSIONS: Our work demonstrates for the first time that Sox2 expression in MB is regulated by the Shh signaling pathway and Sox2+ MB BTICs represent the treatment-resistant clone in Group 2 MBs, suggesting a need for combinatorial therapy as tumors evolve over the course of treatment. Aside from implicating developmental genes and pathways in oncogenesis, we have also demonstrated the importance of studying cancer at a cellular level, as distinct differences in rare subsets of tumor cells may not otherwise be appreciated with genomic profiling of the bulk tumor mass. SECONDARY CATEGORY: Neuropathology & Tumor Biomarkers." @default.
- W2327242544 created "2016-06-24" @default.
- W2327242544 creator A5001141427 @default.
- W2327242544 creator A5002640598 @default.
- W2327242544 creator A5009453448 @default.
- W2327242544 creator A5015278451 @default.
- W2327242544 creator A5043563044 @default.
- W2327242544 creator A5046190195 @default.
- W2327242544 creator A5059911286 @default.
- W2327242544 creator A5073718839 @default.
- W2327242544 creator A5083723060 @default.
- W2327242544 creator A5090078162 @default.
- W2327242544 creator A5066230924 @default.
- W2327242544 date "2014-07-01" @default.
- W2327242544 modified "2023-10-04" @default.
- W2327242544 title "SOX2 IDENTIFIES THE TREATMENT-REFRACTORY STEM CELL POPULATION IN GROUP 2 MEDULLOBLASTOMA" @default.
- W2327242544 doi "https://doi.org/10.1093/neuonc/nou206.16" @default.
- W2327242544 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4144480" @default.
- W2327242544 hasPublicationYear "2014" @default.
- W2327242544 type Work @default.
- W2327242544 sameAs 2327242544 @default.
- W2327242544 citedByCount "1" @default.
- W2327242544 countsByYear W23272425442021 @default.
- W2327242544 crossrefType "journal-article" @default.
- W2327242544 hasAuthorship W2327242544A5001141427 @default.
- W2327242544 hasAuthorship W2327242544A5002640598 @default.
- W2327242544 hasAuthorship W2327242544A5009453448 @default.
- W2327242544 hasAuthorship W2327242544A5015278451 @default.
- W2327242544 hasAuthorship W2327242544A5043563044 @default.
- W2327242544 hasAuthorship W2327242544A5046190195 @default.
- W2327242544 hasAuthorship W2327242544A5059911286 @default.
- W2327242544 hasAuthorship W2327242544A5066230924 @default.
- W2327242544 hasAuthorship W2327242544A5073718839 @default.
- W2327242544 hasAuthorship W2327242544A5083723060 @default.
- W2327242544 hasAuthorship W2327242544A5090078162 @default.
- W2327242544 hasBestOaLocation W23272425441 @default.
- W2327242544 hasConcept C104317684 @default.
- W2327242544 hasConcept C173396325 @default.
- W2327242544 hasConcept C190283241 @default.
- W2327242544 hasConcept C2776637008 @default.
- W2327242544 hasConcept C2777933648 @default.
- W2327242544 hasConcept C2779933373 @default.
- W2327242544 hasConcept C2780789225 @default.
- W2327242544 hasConcept C28328180 @default.
- W2327242544 hasConcept C502942594 @default.
- W2327242544 hasConcept C54355233 @default.
- W2327242544 hasConcept C55427017 @default.
- W2327242544 hasConcept C62478195 @default.
- W2327242544 hasConcept C86339819 @default.
- W2327242544 hasConcept C86803240 @default.
- W2327242544 hasConcept C88498014 @default.
- W2327242544 hasConcept C95444343 @default.
- W2327242544 hasConceptScore W2327242544C104317684 @default.
- W2327242544 hasConceptScore W2327242544C173396325 @default.
- W2327242544 hasConceptScore W2327242544C190283241 @default.
- W2327242544 hasConceptScore W2327242544C2776637008 @default.
- W2327242544 hasConceptScore W2327242544C2777933648 @default.
- W2327242544 hasConceptScore W2327242544C2779933373 @default.
- W2327242544 hasConceptScore W2327242544C2780789225 @default.
- W2327242544 hasConceptScore W2327242544C28328180 @default.
- W2327242544 hasConceptScore W2327242544C502942594 @default.
- W2327242544 hasConceptScore W2327242544C54355233 @default.
- W2327242544 hasConceptScore W2327242544C55427017 @default.
- W2327242544 hasConceptScore W2327242544C62478195 @default.
- W2327242544 hasConceptScore W2327242544C86339819 @default.
- W2327242544 hasConceptScore W2327242544C86803240 @default.
- W2327242544 hasConceptScore W2327242544C88498014 @default.
- W2327242544 hasConceptScore W2327242544C95444343 @default.
- W2327242544 hasLocation W23272425441 @default.
- W2327242544 hasLocation W23272425442 @default.
- W2327242544 hasOpenAccess W2327242544 @default.
- W2327242544 hasPrimaryLocation W23272425441 @default.
- W2327242544 hasRelatedWork W1902157949 @default.
- W2327242544 hasRelatedWork W1999636129 @default.
- W2327242544 hasRelatedWork W2036094848 @default.
- W2327242544 hasRelatedWork W2052950375 @default.
- W2327242544 hasRelatedWork W2112462932 @default.
- W2327242544 hasRelatedWork W2153016097 @default.
- W2327242544 hasRelatedWork W2538756717 @default.
- W2327242544 hasRelatedWork W2580651265 @default.
- W2327242544 hasRelatedWork W2613632249 @default.
- W2327242544 hasRelatedWork W2741344135 @default.
- W2327242544 hasRelatedWork W2884269426 @default.
- W2327242544 hasRelatedWork W2909705871 @default.
- W2327242544 hasRelatedWork W2944861049 @default.
- W2327242544 hasRelatedWork W2955102945 @default.
- W2327242544 hasRelatedWork W3000322478 @default.
- W2327242544 hasRelatedWork W3119839341 @default.
- W2327242544 hasRelatedWork W3134468050 @default.
- W2327242544 hasRelatedWork W3168269203 @default.
- W2327242544 hasRelatedWork W3177663350 @default.
- W2327242544 hasRelatedWork W1831723166 @default.
- W2327242544 isParatext "false" @default.
- W2327242544 isRetracted "false" @default.
- W2327242544 magId "2327242544" @default.
- W2327242544 workType "article" @default.